GeoVax Labs, Inc. Research And Development Expense

• GeoVax Labs, Inc. showed an increase of +14.4% in Research And Development Expense from 2023 to 2024.
• This data is from GeoVax Labs, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
• XBRL data for this metric is available from 2009 to 2024 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2009 to 2024), GeoVax Labs, Inc.'s Research And Development Expense has grown by 482.8%.
• Historical annual values: Fiscal year 2024: $23.71 million | Fiscal year 2023: $20.72 million | Fiscal year 2022: $9.12 million | Fiscal year 2021: $15.55 million | Fiscal year 2020: $2.44 million | Fiscal year 2019: $1.91 million | Fiscal year 2018: $1.88 million | Fiscal year 2017: $2.02 million | Fiscal year 2016: $1.97 million | Fiscal year 2015: $1.69 million | Fiscal year 2014: $1.81 million | Fiscal year 2013: $2.91 million | Fiscal year 2012: $3.04 million | Fiscal year 2011: $4.28 million | Fiscal year 2010: $4.79 million | Fiscal year 2009: $4.07 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026